Recent findings demonstrate that after years of declining incidence, there is a rise in prostate cancer diagnoses, particularly in Black men. Especially concerning is the marked increase in rates of regional and distant-stage prostate cancer at the time of diagnosis—the forms which have the most potential to be lethal irrespective of advances in treatment.
PCF President and CEO Dr. Charles J. Ryan is joined by Founder and Chairman Michael Milken, Board Member Dr. Kneeland Youngblood, and PCF-funded researcher and urologist Dr. Isla Garraway of UCLA to discuss the data, some of the underlying causes, and next steps that PCF is taking to address these disparities.